Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone prolonged-release versus aripiprazole in adolescents with schizophrenia
2009-014811-11Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Paliperidone prolonged-release with Aripiprazole (2 arms). Primary endpoint: Change from baseline in PANSS total score to last post-randomization assessment up to Week 8. Started Oct 2009; status: completed.
02
Drugs
paliperidonearipiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2009-014811-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014811-11.